Pharmaceuticals Stocks

Fundamental analysis of 42 Pharmaceuticals companies

All Sectors (42)

Pharmaceuticals

ABBOTINDIA FY2025

Abbott India

Revenue of ₹6,409 Cr in FY2025.

Rev ₹6,409 Cr +5.1% YoY +10.8% 10Y CAGR PE 38.2

Pharmaceuticals

ADVENZYMES FY2025

Advanced Enzyme

Revenue of ₹637 Cr in FY2025.

Rev ₹637 Cr -3.6% YoY +11.1% 10Y CAGR PE 29.7

Pharmaceuticals

AJANTPHARM FY2025

Ajanta Pharma

Revenue of ₹4,743 Cr in FY2025.

Rev ₹4,743 Cr +10.5% YoY +12.3% 10Y CAGR PE 38.4

Pharmaceuticals

Alembic Pharma

Revenue of ₹6,715 Cr in FY2025.

Rev ₹6,715 Cr +7.3% YoY +12.6% 10Y CAGR PE 25.4

Pharmaceuticals

Alkem Lab

Revenue of ₹13,458 Cr in FY2025.

Rev ₹13,458 Cr +3.7% YoY +13.7% 10Y CAGR PE 29.8

Pharmaceuticals

AMRUTANJAN FY2025

Amrutanjan

Revenue of ₹469 Cr in FY2025.

Rev ₹469 Cr +7.1% YoY +10.9% 10Y CAGR PE 32.5

Pharmaceuticals

ANUHPHARMA FY2025

Anuh Pharma

Revenue of ₹662 Cr in FY2025.

Rev ₹662 Cr +2.2% YoY +8.8% 10Y CAGR PE 17.3

Pharmaceuticals

ASTRAZEN FY2025

AstraZenca Pharma

Revenue grew 32.1% to ₹1,757 Cr in FY2025.

Rev ₹1,757 Cr +32.1% YoY +13.0% 10Y CAGR PE 177.4

Pharmaceuticals

AUROPHARMA FY2025

Aurobindo Pharma

Revenue of ₹32,346 Cr in FY2025.

Rev ₹32,346 Cr +9.4% YoY +10.3% 10Y CAGR PE 23.2

Pharmaceuticals

Biocon

Revenue compounded at 18.2% annually over 10 years.

Rev ₹16,470 Cr +5.4% YoY +18.2% 10Y CAGR PE 42.5

Pharmaceuticals

CAPLIPOINT FY2025

Caplin Point

Revenue grew 15.5% to ₹2,034 Cr in FY2025.

Rev ₹2,034 Cr +15.5% YoY +23.2% 10Y CAGR PE 24.3

Pharmaceuticals

Cipla

Revenue of ₹28,409 Cr in FY2025.

Rev ₹28,409 Cr +7.1% YoY +9.6% 10Y CAGR PE 20.1

Pharmaceuticals

DIVISLAB FY2025

Divis Laboratories

Revenue grew 18.7% to ₹9,712 Cr in FY2025.

Rev ₹9,712 Cr +18.7% YoY +12.0% 10Y CAGR PE 78.8

Pharmaceuticals

Dr Reddy

Revenue grew 16.7% to ₹33,741 Cr in FY2025.

Rev ₹33,741 Cr +16.7% YoY +8.4% 10Y CAGR PE 19.5

Pharmaceuticals

FDC

Revenue of ₹2,199 Cr in FY2025.

Rev ₹2,199 Cr +7.5% YoY +9.5% 10Y CAGR PE 22.2

Pharmaceuticals

Glaxo Pharma

Revenue of ₹3,895 Cr in FY2025.

Rev ₹3,895 Cr +8.9% YoY +3.0% 13Y CAGR PE 42.7

Pharmaceuticals

GLENMARK FY2025

Glenmark Pharma

Turned profitable with net income of ₹1,047 Cr in FY2025.

Rev ₹13,322 Cr +5.3% YoY +7.2% 10Y CAGR PE 64.8

Pharmaceuticals

GRANULES FY2025

Granules

Revenue of ₹4,495 Cr in FY2025.

Rev ₹4,495 Cr -0.4% YoY +13.3% 10Y CAGR PE 33.8

Pharmaceuticals

GUFICBIO FY2025

Gufic Biosciences

Revenue compounded at 18.4% annually over 10 years.

Rev ₹820 Cr +1.4% YoY +18.4% 10Y CAGR PE 40.9

Pharmaceuticals

Indoco Remedies

Reported a net loss of ₹78.0 Cr in FY2025.

Rev ₹1,665 Cr -8.9% YoY +6.9% 10Y CAGR

Pharmaceuticals

Ipca Laboratories

Revenue grew 15.4% to ₹9,032 Cr in FY2025.

Rev ₹9,032 Cr +15.4% YoY +11.1% 10Y CAGR PE 52.6

Pharmaceuticals

JBCHEPHARM FY2025

JB Chemicals

Revenue of ₹3,918 Cr in FY2025.

Rev ₹3,918 Cr +11.3% YoY +13.1% 10Y CAGR PE 49.2

Pharmaceuticals

JENBURKT FY2025

Jenburkt Pharma

Revenue of ₹152 Cr in FY2025.

Rev ₹152 Cr +6.9% YoY +5.9% 10Y CAGR PE 14.4

Pharmaceuticals

JUBLPHARMA FY2025

Jubilant Pharmova

Revenue of ₹7,291 Cr in FY2025.

Rev ₹7,291 Cr +7.7% YoY +2.3% 10Y CAGR PE 17.5

hit counter